Indian pharma stocks rallied after US President Trump imposed sweeping tariffs but exempted the sector. The Nifty Pharma ...
US President Trump announced a 26% reciprocal tariff on India, citing high trade barriers. The move shakes global markets, ...
Trump’s 26% reciprocal tariff on India sparks a sell-off in IT stocks, dragging the Nifty IT index down 17% in 2025. Nasdaq ...